Overview
Portfolio
More
Amboy Street Ventures
Los Angeles, United States
Amboy Street Ventures invests in early‑stage (seed and Series A) startups that are developing innovative technologies and services for women’s health and sexual wellbeing. The firm focuses on solutions across fertility,...
Portfolio
18+
Employees
10+
Founded
N/A
AUM
≈ $0.0
Investment focus
Stages
Seed → Series A
Industries
Healthcare Technology
Geographic scope
Global
Sources
Amboy Street Ventures
Amboy Street Ventures invests in early‑stage (seed and Series A) startups that are developing innovative technologies and services for women’s health and sexual wellbeing. The firm focuses on solutions across fertility, menopause, maternal health, LGBTQ+ health, menstruation, hormonal health, contraception and related areas, aiming to unlock the $1 trillion global market opportunity.
Portfolio
18+
Employees
10+
Founded
N/A
AUM
≈ $0.0
Stages
Seed → Series A
Industries
Healthcare Technology
Geographic scope
Global
Sources
Showing 18 of 18 matched portfolio companies
This company provides telehealth services specializing in midlife women's health, focusing primarily on menopause symptom management. They connect patients with menopause-trained physicians for personalized treatment plans, including prescription medication and specialized skincare. Treatments for menopause, weight management, sexual health, and hair loss are delivered directly to the patient with ongoing virtual support.
Funding: $21.3M
Rough estimate of the amount of funding raised
Funding: $21.3M
Rough estimate of the amount of funding raised
Allswell provides virtual, LGBTQ+‑affirming therapy for adults in Maryland, DC, and Virginia, with sessions covered by Medicaid and major commercial insurers. The platform matches clients with licensed, trauma‑focused therapists and combines one‑on‑one video sessions with peer‑support groups, using evidence‑based modalities such as EMDR, CBT, DBT, and IFS within an identity‑affirming framework.
Funding: $1.3M
Rough estimate of the amount of funding raised
Funding: $1.3M
Rough estimate of the amount of funding raised
This startup produces biodegradable tampons and pads made from organic cotton, ensuring that menstrual products are accessible to all individuals with periods. By providing free-vend, wall-mounted dispensers, the company enables businesses and schools to offer these essential hygiene products at no cost to employees, students, and guests.
Funding: $10.7M
Rough estimate of the amount of funding raised
Funding: $10.7M
Rough estimate of the amount of funding raised
Béa Fertility provides clinical fertility treatment delivered directly to the patient's home, guided by specialists. The service utilizes an FDA-cleared insemination device as part of a simple, injection-free treatment plan that avoids clinic visits. This approach offers accessible, clinician-guided care designed to support individuals experiencing unexplained infertility or mild to moderate male factor infertility.
Funding: $4.8M
Rough estimate of the amount of funding raised
Funding: $4.8M
Rough estimate of the amount of funding raised
Contraline is developing ADAM™, a long-lasting, non-hormonal implant for male contraception that functions similarly to an IUD. This device addresses the need for a reliable and reversible contraceptive option for men, eliminating the anxiety and inconvenience associated with current methods.
Funding: $35.9M
Rough estimate of the amount of funding raised
Funding: $35.9M
Rough estimate of the amount of funding raised
Dame Products designs and sells medical‑grade silicone vibrators and sexual‑health accessories featuring ergonomic shapes, quiet brushless motors, and USB‑C fast charging. All items are waterproof, doctor‑approved, and include a three‑year warranty and 60‑day satisfaction guarantee, while a subscription service delivers ultra‑thin condoms monthly. The direct‑to‑consumer model offers a discreet e‑commerce experience for individuals and couples seeking body‑safe intimacy products.
Funding: $7.0M
Rough estimate of the amount of funding raised
Funding: $7.0M
Rough estimate of the amount of funding raised
Defiant Health operates a virtual breast‑cancer clinic that offers same‑week telehealth consultations with board‑certified breast‑health physicians, applies Dana‑Farber‑derived diagnostic protocols, and coordinates imaging, laboratory tests, and specialist referrals through an automated workflow. The platform provides a secure, HIPAA‑compliant dashboard with test results and a personalized care plan for a flat $199 fee, while imaging and labs are billed directly to insurance. It serves U.S.
This company provides at-home vaginal microbiome testing using CLIA-certified metagenomic sequencing to analyze over 700 bacteria and fungi. Results are reviewed by clinicians who offer personalized insights and custom care plans, including prescription treatment options when eligible. The platform supports proactive vaginal health management related to symptoms, fertility, and menopause.
50+
10K+Approximate amount of employees
Funding: $14.0M
Rough estimate of the amount of funding raised
Funding: $14.0M
Rough estimate of the amount of funding raised
Gennev provides a fully virtual menopause care platform that connects board‑certified physicians and registered dietitian nutritionists with women in perimenopause and post‑menopause. Through a brief questionnaire and a 30‑minute video visit, patients receive coordinated medical, prescription, and lifestyle treatment plans, with insurance billing and same‑day e‑prescriptions available nationwide.
Gesynta Pharma develops pharmaceuticals that inhibit the pro-inflammatory enzyme mPGES-1 to reduce inflammation and pain associated with chronic conditions like endometriosis. Their lead candidate, Vipoglanstat, is currently in phase II clinical trials, demonstrating significant reductions in endometrial lesions and pain-related symptoms.
Funding: $57.7M
Rough estimate of the amount of funding raised
Funding: $57.7M
Rough estimate of the amount of funding raised
Granata Bio is a biopharmaceutical company focused on developing therapeutics for reproductive health, specifically targeting ovarian stimulation and luteal phase support in infertility treatments. By conducting rigorous safety and efficacy evaluations, Granata Bio aims to enhance the availability and effectiveness of fertility solutions in North America.
Funding: $31.1M
Rough estimate of the amount of funding raised
Funding: $31.1M
Rough estimate of the amount of funding raised
HerMD provides comprehensive, evidence-based virtual women’s healthcare across all 50 states. The platform focuses on delivering longer appointment times and compassionate support for specialized needs including menopause, sexual health, and hormonal care. Patients receive personalized treatment plans from expert clinicians in the privacy of their homes.
Funding: $18.0M
Rough estimate of the amount of funding raised
Funding: $18.0M
Rough estimate of the amount of funding raised
Hey Jane provides a fully virtual reproductive and sexual health service in the U.S., connecting patients with licensed clinicians via secure chat, phone, or video to prescribe FDA‑approved medication abortions, birth‑control, emergency contraception, and treatments for common infections. Prescriptions are delivered to a local pharmacy for discreet pickup or mailed in unbranded packaging, with insurance, Medicaid, and income‑based pricing options to keep care affordable.
Funding: $6.1M
Rough estimate of the amount of funding raised
Funding: $6.1M
Rough estimate of the amount of funding raised
Juniper Genomics employs whole genome and transcriptome sequencing along with proprietary data analysis to enhance embryo selection in in vitro fertilization (IVF). By providing personalized insights based on comprehensive genetic data, the company increases the likelihood of successful embryo transfers, thereby improving IVF outcomes.
Funding: $2.8M
Rough estimate of the amount of funding raised
Funding: $2.8M
Rough estimate of the amount of funding raised
Millie Clinic provides midwifery‑led, coordinated women’s health care that combines obstetric, gynecologic, and hormonal services through in‑person and virtual visits. Certified nurse‑midwives act as primary clinicians, supported by OB‑GYNs and specialists for complex cases, while a dedicated doula and a mobile app deliver continuous prenatal, postpartum, and wellness support. The model includes comprehensive services such as fertility assessments, hormone therapy, birth‑control options, and postpartum home visits, all accepted by major insurance plans.
Funding: $12.0M
Rough estimate of the amount of funding raised
Funding: $12.0M
Rough estimate of the amount of funding raised
This startup provides specialized physical therapy and expert care services for women experiencing health issues related to pregnancy, postpartum, menopause, and sexual health. By offering both in-person and virtual sessions, along with tailored exercise programs and educational resources, the company ensures accessible treatment options that are covered by insurance.
Playground develops clinically validated, plant-based sexual health products specifically formulated for women, addressing issues such as vaginal irritation and discomfort. Their offerings, including water-based lubricants and intimacy oils, utilize ingredients like hyaluronic acid and adaptogens to enhance pleasure while promoting overall vaginal health.
Funding: $2.2M
Rough estimate of the amount of funding raised
Funding: $2.2M
Rough estimate of the amount of funding raised
Testmate Health develops self-testing kits that provide rapid diagnostic results at home, eliminating the need for in-person visits. This technology addresses the delay and inconvenience associated with traditional testing methods, enabling users to receive results in minutes.
Funding: $7.8M
Rough estimate of the amount of funding raised
Funding: $7.8M
Rough estimate of the amount of funding raised